NANT CANCER VACCINE
Live / Applied — Fourth extension granted (statement of use) (as of 03 Oct 2025)
What this means for you
Not registered yet, but its 17 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97800687
- Mark type
- Stylized text
- Filed
- 17 Feb 2023
- Published for opposition
- 08 Aug 2023
- Attorney of record
- Michael J. McCue
Goods and services
- Class 042 — Scientific and technological services: Medical and pharmaceutical research and development services; medical and scientific research in the fields of pharmaceuticals, oncology, cancer, immune-oncology, immunotherapy, autoimmune diseases, infectious diseases, human diseases, animal diseases, and vaccines; product development in the fields of pharmaceuticals, oncology, cancer, immune-oncology, immunotherapy, autoimmune diseases, infectious diseases, human diseases, animal diseases, vaccines, biologics, cells and cell derived preparations
Owner
- Nant Holdings IP, LLC, Culver City, CA, US
- Nant Holdings IP, LLC, Culver City, CA, US
Prior registrations
Prosecution history
- 24 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 04 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Oct 2025 — SOU EXTENSION 4 GRANTED
- 03 Oct 2025 — SOU EXTENSION 4 FILED
- 03 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 27 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Mar 2025 — SOU EXTENSION 3 GRANTED
- 26 Mar 2025 — SOU EXTENSION 3 FILED
- 26 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Oct 2024 — SOU EXTENSION 2 GRANTED
- 03 Oct 2024 — SOU EXTENSION 2 FILED
- 03 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 02 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Apr 2024 — SOU EXTENSION 1 GRANTED